CASE REPORT |
|
Year : 2015 | Volume
: 8
| Issue : 3 | Page : 411-413 |
|
Chronic subdural hematoma-unsual cause of headache in a patient with chronic myeloid leukemia treated with high-dose imatinib mesylate: A rare case report with review of literature
Sanjay M Khaladkar, Dhaval K Thakkar, Mansi N Jantre, Vilas M Kulkarni, Amarjit Singh
Department of Radio-Diagnosis, Dr. D.Y. Patil Medical College, Pimpri, Pune, Maharashtra, India
Correspondence Address:
Sanjay M Khaladkar Flat No. 5, Plot No. 8, S. No. 26/A, Tejas Bldg, Sahawas Society, Karve Nagar, Pune - 411 052, Maharashtra India
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/0975-2870.157113
|
|
Head injury is considered one of the single most important causes of subdural hematoma. Other cause include bleeding diasthesis. We report here a case of 70-year-old female patient with chronic myeloid leukemia (CML) presenting with bilateral chronic subdural hematoma after an incremental high-dose of imatinib mesylate (IM) due to loss of complete molecular response. IM is useful to treat a wide range of diseases, including Philadelphia chromosome-positive CML, as it has high tolerability and low incidence of minor side effects. Hemorrhage is a rare complication of IM. IM is associated with reduced α2-plasmin inhibitor and platelet dysfunction. This case report emphasizes on the need to consider chronic subdural hematoma as atypical cause of headache in a patient of CML taking high-dose IM. |
|
|
|
[FULL TEXT] [PDF]* |
|
|
|